>
Switch to:

Travere Therapeutics COGS-to-Revenue

: 0.02 (As of Sep. 2020)
View and export this data going back to 2003. Start your Free Trial

Travere Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2020 was $1.2 Mil. Its Revenue for the three months ended in Sep. 2020 was $51.1 Mil.

Travere Therapeutics's COGS to Revenue for the three months ended in Sep. 2020 was 0.02.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Travere Therapeutics's Gross Margin % for the three months ended in Sep. 2020 was 97.67%.


Travere Therapeutics COGS-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Travere Therapeutics Annual Data
Feb11 Feb12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
COGS-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.02 0.03 0.03

Travere Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
COGS-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.04 0.03 0.03 0.02

Travere Therapeutics COGS-to-Revenue Calculation

Travere Therapeutics's COGS to Revenue for the fiscal year that ended in Dec. 2019 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=5.234 / 175.338
=0.03

Travere Therapeutics's COGS to Revenue for the quarter that ended in Sep. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.189 / 51.139
=0.02

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Travere Therapeutics  (NAS:TVTX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Travere Therapeutics's Gross Margin % for the three months ended in Sep. 2020 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.189 / 51.139
=97.67 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Travere Therapeutics COGS-to-Revenue Related Terms


Travere Therapeutics COGS-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)